These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31256285)

  • 1. Cut-off value of mal-apposition volume and depth for resolution at early phase of acute incomplete stent apposition after CoCr-EES implantation.
    Uchimura Y; Itoh T; Oda H; Taguchi Y; Sasaki W; Kaneko K; Sakamoto T; Goto I; Sakuma M; Ishida M; Kikuchi T; Terashita D; Otake H; Morino Y; Shinke T
    Int J Cardiovasc Imaging; 2019 Nov; 35(11):1979-1987. PubMed ID: 31256285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cut-off value of strut-vessel distance for the resolution of acute incomplete stent apposition in the early phase using serial optical coherence tomography after cobalt-chromium everolimus-eluting stent implantation.
    Oda H; Itoh T; Sasaki W; Uchimura Y; Taguchi Y; Kaneko K; Sakamoto T; Goto I; Sakuma M; Ishida M; Kikuchi T; Terashita D; Otake H; Morino Y; Shinke T
    J Cardiol; 2020 Jun; 75(6):641-647. PubMed ID: 31924410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal changes of incomplete stent apposition during early phase after everolimus-eluting stent implantation: serial optical coherence tomography analyses at 2-week and 4-month.
    Wakabayashi H; Ando H; Nakano Y; Takashima H; Waseda K; Shimoda M; Ohashi H; Suzuki A; Sakurai S; Amano T
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):411-417. PubMed ID: 32926310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial optical coherence tomography assessment of malapposed struts after everolimus-eluting stent implantation. A subanalysis from the HEAL-EES study.
    Ishida K; Otsuki S; Giacchi G; Ortega-Paz L; Shiratori Y; Freixa X; Martín-Yuste V; Masotti M; Sabaté M; Brugaletta S
    Cardiovasc Revasc Med; 2017; 18(1):47-52. PubMed ID: 27634493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial.
    Sotomi Y; Onuma Y; Dijkstra J; Miyazaki Y; Kozuma K; Tanabe K; Popma JJ; de Winter RJ; Serruys PW; Kimura T
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):59-66. PubMed ID: 28158421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis.
    Jaguszewski M; Aloysius R; Wang W; Bezerra HG; Hill J; De Winter RJ; Karjalainen PP; Verheye S; Wijns W; Lüscher TF; Joner M; Costa M; Landmesser U
    JACC Cardiovasc Interv; 2017 Mar; 10(5):489-499. PubMed ID: 28279316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of vascular responses after different types of second-generation drug-eluting stents implantation detected by optical coherence tomography.
    Ohtani H; Kimura S; Sugiyama T; Hishikari K; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Kojima K; Sagawa Y; Hikita H; Ashikaga T; Takahashi A; Isobe M
    Int J Cardiovasc Imaging; 2017 Feb; 33(2):177-186. PubMed ID: 27761750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of acute stent malapposition between platinum-chromium versus cobalt-chromium everolimus-eluting stents.
    Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):269-77. PubMed ID: 25345751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serial optical coherence tomography imaging following aggressive stent expansion technique: insight from the MECHANISM study.
    Sasaki W; Ishida M; Itoh T; Uchimura Y; Oda H; Taguchi Y; Kaneko K; Sakamoto T; Goto I; Sakuma M; Terashita D; Otake H; Shinke T; Morino Y
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):419-428. PubMed ID: 33034867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary risk factors associated with OCT macrophage images and their response after CoCr everolimus-eluting stent implantation in patients with stable coronary artery disease.
    Taguchi Y; Itoh T; Oda H; Uchimura Y; Kaneko K; Sakamoto T; Goto I; Sakuma M; Ishida M; Terashita D; Otake H; Morino Y; Shinke T
    Atherosclerosis; 2017 Oct; 265():117-123. PubMed ID: 28881269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of everolimus-eluting stent incomplete stent apposition: a serial optical coherence tomography analysis.
    Shimamura K; Kubo T; Akasaka T; Kozuma K; Kimura K; Kawamura M; Sumiyoshi T; Ino Y; Yoshiyama M; Sonoda S; Igarashi K; Miyazawa A; Uzui H; Sakanoue Y; Shinke T; Morino Y; Tanabe K; Kadota K; Kimura T
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):23-8. PubMed ID: 25342855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial.
    Kelly CR; Teirstein PS; Meredith IT; Farah B; Dubois CL; Feldman RL; Dens J; Hagiwara N; Rabinowitz A; Carrié D; Pompili V; Bouchard A; Saito S; Allocco DJ; Dawkins KD; Stone GW
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2392-2400. PubMed ID: 29217001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation.
    de la Torre Hernández JM; Tejedor P; Camarero TG; Duran JM; Lee DH; Monedero J; Laso FS; Calderón MA; Veiga G; Zueco J
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):E67-73. PubMed ID: 26526783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very early neointimal coverage of new biodegradable polymer drug-eluting stent compared with durable polymer everolimus-eluting stent evaluated by optical frequency domain imaging.
    Kobayashi N; Ito Y; Yamawaki M; Araki M; Sakai T; Sakamoto Y; Mori S; Tsutsumi M; Nauchi M; Honda Y; Tokuda T; Makino K; Shirai S; Hirano K
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):515-522. PubMed ID: 29159531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very late-phase vascular response after everolimus-eluting stent implantation assessed by optical coherence tomography.
    Khalifa AKM; Ino Y; Kubo T; Tanimoto T; Shimamura K; Shiono Y; Takahata M; Terada K; Higashioka D; Wada T; Taruya A; Emori H; Katayama Y; Kashiwagi M; Kuroi A; Matsuo Y; Fujita S; Tanaka A; Hozumi T; Akasaka T
    Int J Cardiovasc Imaging; 2020 Sep; 36(9):1627-1635. PubMed ID: 32385540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy outcomes of second-generation everolimus-eluting stents in octogenarians compared to non-octogenarians.
    Kitabata H; Kubo T; Mori K; Yamamoto Y; Kashiwagi M; Arita Y; Tanimoto T; Akasaka T
    Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):12-16. PubMed ID: 28600019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting Stents.
    Han Y; Xu B; Fu G; Wang X; Xu K; Jin C; Tao L; Li L; Hou Y; Su X; Fang Q; Chen L; Liu H; Wang B; Yuan Z; Gao C; Zhou S; Sun Z; Zhao Y; Guan C; Stone GW;
    JACC Cardiovasc Interv; 2018 Feb; 11(3):260-272. PubMed ID: 29413240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study.
    Vesga B; Hernandez H; Moncada M; Gasior P; Higuera S; Dager A; Arana C; Delgado JA; Généreux P; Maehara A; Granada JF
    Coron Artery Dis; 2017 Mar; 28(2):126-134. PubMed ID: 27879518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of long-term in-stent vascular response between abluminal groove-filled biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent: 3-year OCT follow-up from the TARGET I trial.
    Xu B; Zhang YJ; Sun ZW; Qiao SB; Chen SL; Zhang RY; Pan DR; Pang S; Zhang Q; Xu L; Yang YJ; Leon MB; Gao RL
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1489-96. PubMed ID: 26208685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of total stent length after cobalt chromium everolimus-eluting stent implantation on 3-year clinical outcomes.
    Hiromasa T; Kuramitsu S; Shinozaki T; Jinnouchi H; Morinaga T; Kobayashi Y; Domei T; Soga Y; Shirai S; Ando K
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):207-216. PubMed ID: 26910036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.